Savient (SVNT) Rises 55% On Bad News
Shares in pharma firm Savient (SVNT) are up 55% to $9.13 on what would appear to be very bad news. The FDA issued a statement saying it has safety concerns about the company’s gout drug. According to…
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 343Analyst Projecting 50% Upside in Dendreon (DNDN)
Dendreon Corporation (NASDAQ: DNDN) was started with a Buy rating and a $36.00 target at Deutsche Bank. The call’s positive expectations are mixed near-term, but the assumption is that Provenge will become a blockbuster…
ASCO Winner: Biovest May Be The Next Dendreon (BVTI, ABPIQ, DNDN)
One of the largest percentage gainers with data released at the American Society of Clinical Oncology was none other than an OTC micro-cap company called Biovest International, Inc. (OTC: BVTI). Technically, this is a…
Full 2009 ASCO Cancer & Oncology Primer (ABII, AEZS, ALTH, AMGN, APPA, ARQL, BMY, CLDX, CELG, CTIC, CGRB, LLY, EXEL, GHDX, GSK, IMGN, MEDX, MDVN, MITI, OGXI, OSIP, PPHM, PFE, ROSG, SNTA, TRBN, ZIOP, ZGEN)
We have compiled an updated lengthy 2009 American Society of Clinical Oncology, or ASCO, document showing many company cancer data presentations slated to start this weekend. This is broken down in drug and biotech…
Can Nanotech Make A Comeback For Investors? (ALTI, IBM, TINY, NSPH, PXN)
How long has it been since nanotechnology was on the tip of everyone’s tongue as the next great speculative investment frontier? It seems like ancient history. But we have seen news from Altair Nanotechnologies…
Cramer Outlines The Obama Target List (COF, ACI, MEE, X, SO)
Tonight on CNBC’s MAD MONEY, Jim Cramer came out with several sectors that he thinks that President Obama will be trying to change, and noted Nancy Pelosi is in the fold as well. He…
XOMA’s Hijack Financing On News (XOMA)
XOMA Ltd. (NASDAQ: XOMA) has seen shares on a tear yesterday and then again this morning. It was late yesterday that the company said it would also be entitled to royalties from its partner’s…
Previewing 2009 ASCO Abstracts (ABII, ALTH, ARQL, CLDX, CTIC, CGRB, LLY, EXEL, GHDX, GSK, IMGN, MEDX, MDVN, OGXI, OSIP, PPHM, PFE, SNTA, ZIOP)
We are just about to get the first round of abstracts from companies presenting data at this year’s American Society of Clinical Oncology meeting for 2009. At BioHealthInvestor.com we compiled a brief summary for…
Medarex Positive Data in Rheumatoid Arthritis Trial (MEDX)
Medarex, Inc. (NASDAQ: MEDX) announced that its wholly owned MDX-1100 met its primary endpoints for patients receiving methotrexate in a Phase II ‘proof of concept’ trial in patients with active rheumatoid arthritis. The trial…
Many Biotechs Barely On Life Support (BPAX, CEGE, EPIX, IDMI, LJPC, NRGN, NFLD, TPTX)
We have run a watch list of companies under their own strategic review, and the number of biotech (or grouped with biotech) stocks under this description is just staggering. We published a full review…
Medicare Shoots Down Virtual Colonoscopy Reimbursement (GE, SI)
Today was a big day for the world of colonoscopies and the battle in detecting colon cancer and polyps. The Center for Medicare and Medicaid Services issued a final decision that Medicare would not…
FDA Attacks Cheerios Over Claims as a Drug (GIS)
General Mills, Inc. (NYSE: GIS) maybe facing the same types of battles many supplement and diet product companies have seen with the FDA over advertising claims. The good news is that this is not…
Dendreon Takes In More Than $200 Million in New Cash (DNDN)
Dendreon Corporation (NASDAQ: DNDN) is selling stock to raise cash. The company has announced a spot secondary offering of 10.7 million shares in a public secondary offering of common stock. This comes on the…
GE (GE): Bringing Down The Costs Of Medical Equipment
GE (GE) announced a push to increase R&D in its medical division, bring down prices for many of the technologies it creates, and provide financing to the doctors and hospitals who use the GE…
Speculative Swine Flu Stocks Make Last Stand (NVAX, GNBT, BCRX, PURE, VICL, VIVO, AVII)
It looks like everyone has figured out that swine flu was more of a media pandemic rather than a disease or viral pandemic. Had this been November as flu season was starting, that might…